Addressing ART Safety and Tolerability in Transgender Individuals

CCO Infectious Disease Podcast

内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容（包括剧集、图形和播客描述）均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

1+ y ago 18:01

MP3•单集首页

In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:

Strategies on how to approach different ARV-related toxicities
Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors)
Clinically relevant drug–drug interactions related to HIV and gender-affirming care
Methods to reduce barriers to ART adherence

Faculty:

Jill Blumenthal, MD, MAS
Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jennifer Cocohoba, PharmD
Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Women’s HIV Program
University of California San Francisco Medical Center
San Francisco, California

Link to full program:
https://bit.ly/3PM3nYe

Follow along with the slides at:
https://bit.ly/3NpAYI1

378集单集

#Science #Fitness #Biology #Higher Education #Podcasting Education #Medicine #Clinical Care Options, LLC #Clinical Care Options #HIV #On Covid19 #CME #Hepatitis B #Hbv #Infectious Disease Medical Education #Id Medical Education #Coronavirus #Hepatitis C #Hcv